Re-hospital Agitation and Sedation Trial: A Randomized Controlled Trial of Haloperidol Versus Midazolam for the Sedation of the Agitated Patient
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 10
- 试验地点
- 1
- 主要终点
- Time to sedation
研究概览
简要总结
PREHOSPITAL AGITATION AND SEDATION TRIAL (PHAST)
- The goal of the PHAST is to demine whether haloperidol is superior to midazolam for the sedation of agitated patients in the prehospital environment
- The primary outcome is the time to a Richmond Agitation and Sedation Scale (RASS) ≤1
o The RASS is a well validated standardized score to measure a patient's agitation
-
The secondary outcomes are
-
Time until RASS returns to 0 or 1 if RASS <0
-
Need for additional sedation
-
Adverse effects (need for intubation, arrhythmia)
-
Mercy EMS will be the only EMS agency in the Commonwealth of Pennsylvania carrying haloperidol
-
Identification of potential study patients will be per state protocols
-
Exclusion Criteria for the study
-
Age <18
-
Pregnant
-
Allergic to study medication
-
Transport to hospital other than Mercy Fitzgerald Hospital
-
Unable to reach medical command prior to giving medication
-
When a paramedic identifies a possible study candidate, the paramedic will consult medical command to see if the patient is appropriate for the study
-
If the medical command agrees the patient is appropriate for the study, patients will be randomized to
-
Odd days: Haloperidol 5mg IM (age <65) or haloperidol 2.5 mg IM (age ≥65)
-
Even days: Midazolam 0.05 mg IM to maximum of 5mg IM (age <65) or maximum of 2.5mg (age ≥65)
-
The RASS will be documented by the prehospital providers every 5 minutes until arrival at the hospital
-
Once the patient arrives at the ED, the RASS will be documented in PICIS® by the emergency department nurse at the time of triage and at a minimum of hourly until the RASS =0 or 1 for 2 consecutive hours
-
Questions may be directed to Dr. Isenberg at disenberg@mercyhealth.org or at (267) 205-6453
Richmond Agitation Sedation Scale
RASS RASS Description
-
4 Combative, violent, danger to staff
-
3 Pulls or removes tube(s) or catheters; aggressive
-
2 Frequent non-purposeful movement
-
1 Anxious, apprehensive, but not aggressive 0 Alert and calm
-
1 Awakens to voice (eye opening/contact) >10 sec
-
2 Light sedation, briefly awakens to voice (eye opening/contact) <10 sec
-
3 Moderate sedation, movement or eye opening. No eye contact
-
4 Deep sedation, no response to voice, but movement or eye opening to physical stimulation
-
5 Unarousable, no response to voice or physical stimulation
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- •Allergic to study medication
- •Transport to hospital other than Mercy Fitzgerald Hospital
- •Unable to reach medical command prior to giving medication
研究组 & 干预措施
Haloperidol
IM Haloperidol
干预措施: Haloperidol (Drug)
IM Midazolam
干预措施: Midazolam (Drug)
结局指标
主要结局
Time to sedation
时间窗: 10 minutes
次要结局
未报告次要终点
研究者
Derek Isenberg
MD
Catholic Health East
